VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Events & Presentations
BRIDGEWATER, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that it will report its financial results for the third quarter ended September 30, 2020, on Thursday, November 5, 2020, before the market opens. VYNE will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide a corporate update. Conference Call Thursday, November 5th @ 8:30am Eastern Time Toll Free: 800-289-0438 International: 323-794-2423 Conference ID: 9576782 Webcast: http://public.viavid.com/index.php?id=142196 A replay of the…
VYNE Therapeutics Inc. hosted an event for investors on Thursday, October 1, 2020 from 12pm – 3pm ET. The webinar will feature presentations by nationally recognized dermatologists Ted Lain, M.D. (Sanova Dermatology), Julian Moore, FAAD (Hollywood Dermatology) and Linda Stein Gold, M.D. (Henry Ford Health System).
BRIDGEWATER, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present at the upcoming H.C. Wainwright 22nd Annual Global Investment Conference and the Cantor Fitzgerald Virtual Global Healthcare Conference.